Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins

Nature

Volumn 407, Issue 6804, 2000, Pages 592-598

  Lasorella, Anna ^a   Noseda, Michela ^a   Beyna, Mercedes ^a   Iavarone, Antonio ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN ID2; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; GENE OVEREXPRESSION; HEMATOPOIESIS; NERVOUS SYSTEM DEVELOPMENT; NEUROBLASTOMA; NONHUMAN; ONCOGENE MYC; PRIORITY JOURNAL; PROTEIN ANALYSIS; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMAL; CELL CYCLE; CELL LINE; CROSSES, GENETIC; DNA-BINDING PROTEINS; EMBRYO; EMBRYO AND FETAL DEVELOPMENT; FEMALE; GENE EXPRESSION REGULATION; HEMATOPOIESIS; HUMAN; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; MUSCLE, SKELETAL; MUTATION; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-MYC; RETINOBLASTOMA; RETINOBLASTOMA PROTEIN; SIGNAL TRANSDUCTION; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR CELLS, CULTURED;

EID: 0034609818     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/35036504     Document Type: Article

References (41)

1. Norton, J. D., Deed, R. W., Craggs, G. & Sablitzky, F. Id helix-loop-helix proteins in cell growth and differentiation. Trends Cell Biol. 8, 58-65 (1998).
2. Massari, M. E. & Murre, C. Helix-loop-helix proteins; regulators of transcription in eucaryotic organisms. Mol. Cell. Biol. 20, 429-440 (2000).
3. Iavarone, A., Garg, P., Lasorella, A., Hsu, J. & Israel, M. A. The helix-loop-helix protein Id-2 enhances cell proliferation and binds to the retinoblastoma protein. Genes Dev. 8, 1270-1284 (1994).
4. Lasorella, A., Iavarone, A. & Israel, M. A. Id2 specifically alters regulation of the cell cycle by tumor suppressor proteins. Mol. Cell. Biol. 16, 2570-2578 (1996).
5. Clarke, A. R. et al. Requirement for a functional Rb-1 gene in murine development. Nature 359, 328-330 (1992).
6. Jacks, T. et al. Effects of an Rb mutation in the mouse. Nature 359, 295-300 (1992).
7. Lee, E. Y. -H. P. et al. Mice deficient for Rb are nonviable and show defects in neurogenesis and hematopoesis. Nature 359, 288-294 (1992).
8. Zacksenhaus, E. et al. pRb controls proliferation, differentiation, and death of skeletal muscle cells and other lineages during embryogenesis. Genes Dev. 10, 3051-3064 (1996).
9. Lee, E. Y. et al. Dual roles of the retinoblastoma protein in cell cycle regulation and neuron differentiation. Genes Dev. 8, 2008-2021 (1994).
10. Jen, Y., Manova, K. & Benezra, R. Each member of the Id gene family exhibits a unique expression pattern in mouse gastrulation and neurogenesis. Dev. Dyn. 208, 92-106 (1997).
11. Neuman, T. et al. Neuronal expression of regulatory helix-loop-helix factor Id2 gene in mouse. Dev. Biol. 160, 186-195 (1993).
12. Zhu, W. et al. Id gene expression during development and molecular cloning of the human Id-1 gene. Brain Res. Mol. Brain Res. 30, 312-326 (1995).
13. Sherr, C. J. Cancer cell cycles. Science 274, 1672-1677 (1996).
14. Weinberg, R. A. The retinoblastoma protein and cell cycle control. Cell 81, 323-330 (1995).
15. Martinsen, B. J. & Bronner-Fraser, M. Neural crest specification regulated by the helix-loop-helix repressor Id2. Science 281, 988-991 (1998).
16. Maris, J. M. & Matthay, K. K. Molecular biology of neuroblastoma. J. Clin. Oncol. 17, 2264-2279 (1999).
17. Easton, J., Wei, T., Lahti, J. M. & Kidd, V. J. Disruption of the cyclin D/cydin-dependent kinase/INK4/ retinoblastoma protein regulatory pathway in human neuroblasloma. Cancer Res. 58, 2624-2632 (1998).
18. Beltinger, C. P., White, P. S., Sulman, E. P., Maris, J. M. & Brodeur, G. M. No CDKN2 mutations in neuroblastomas. Cancer Res. 55, 2053-2055 (1995).
19. Diccianni, M. B., Chau, L. S., Batova, A., Vu, T. Q. & Yu, A. L. The p16 and p18 tumor suppressor genes in neuroblastoma: implications for drug resistance. Cancer Lett. 104, 183-192 (1996).
20. Diccianni, M. B. et al. Frequent deregulation of p16 and the p16/G1 cell cycle-regulatory pathway in neuroblastoma. Int. J. Cancer 80, 145-154 (1999).
21. Castresana, J. S., Gomez, L., Garcia-Miguel, P., Queizan, A. & Pestana, A. Mutational analysis of the p16 gene in human neuroblastomas. Mol. Carcinog. 18, 129-133 (1997).
22. Kawamata, N., Seriu, T., Koeffler, H. P. & Bartram, C. R. Molecular analysis of the cyclin-dependent kinase inhibitor family: p16(CDKN2/MTS1/INK4A), p18(INK4C) and p27(Kip1) genes in neuroblastomas. Cancer 77, 570-575 (1996).
23. Fan, X., Gomez, L., Nistal, M., Sierrasesumaga, L. & Castresana, J. S. Lack of gene amplification as a mechanism of CDK4 activation in human neuroblastoma. Oncol. Rep. 6, 647-650 (1999).
24. Alevizopoulos, K., Vlach, J., Hennecke, S. & Amati, B. Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins. EMBO J. 16, 5322-5333 (1997).
25. Goodrich, D. W. & Lee, W. H. Abrogation by c-Myc of G1 phase arrest induced by RB protein but not by p53 [published erratum: Nature 360, 491 (1992)]. Nature 360, 177-179 (1992).
26. Arnati, B., Alevizopoulos, K. & Vlach, J. Myc and the cell cycle. Front Biosci. 3, D250-268 (1998).
27. Slack, R. S., El-Bizri, H., Wong, J., Belliveau, D. J. & Miller, F. D. A critical temporal requirement for the retinoblastoma protein family during neuronal determination. J. Cell Biol. 140, 1497-1509 (1998).
28. Iavarone, A. & Massague, J. Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-beta in cells lacking the CDK inhibitor p15. Nature 387, 417-422 (1997).
29. Pietenpol, J. A. et al. TGF-β1 Inhibition of c-Myc transcription and growth in keratinocytes is abrogated by viral transforming protein with pRB binding domeins. Cell 61, 777-785 (1990).
30. Neuman, K., Nornes, H. O. & Neuman, T Helix-loop-helix transcription factors regulate Id2 gene promoter activity. FEBS Lett. 374, 279-283 (1995).
31. Boyd, K. E., Wells, J., Gutman. J., Bartley, S. M & Farnham, P. J. c-Myc target gene specificity is determined by a post-DNA-binding mechanism. Proc. Natl Acad. Sci. USA 95, 13887-13892 (1998).
32. Morrow, M. A., Mayer, E. W., Perez, C. A., Adlam, M. & Siu, G. Overexpression of the Helix-Loop-Helix protein Id2 blocks T cell development at multiple stages. Mol. Immunol. 36, 491-503 (1999).
33. Florio, M. et al. Id2 promotes apoptosis by a novel mechanism independent of dimerization to basic helix-loop-helix factors. Mol. Cell. Biol. 18, 5435-5444 (1998).
34. Cooper, C. L., Brady, G., Bilia, F., Iscove, N. N. & Quesenberry, P. J. Expression of the Id family helix-loop-helix regulators during growth and development in the hematopoietic system. Blood 89, 3155-3165 (1997).
35. Tsai, K. Y. et al. Mutation of E2f-1 suppresses apoptosis and inappropriate S phase entry and extends survival of Rb-deficient mouse embryos. Mol. Cell 2, 293-304 (1998).
36. Jen, Y., Manova, K. & Benezra, R. Expression patterns of Id1, Id2, and Id3 are highly related but distinct from that of Id4 during mouse embryogenesis. Dev. Dyn. 207, 235-252 (1996).
37. Yokota, Y. et al. Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2. Nature 397, 702-706 (1999).
38. Lufkin, T. et al. Homeotic transformation of the occipital bones of the skull by ectopic expression of a homeobox gene. Nature 359, 835-841 (1992).
39. Jacobs, J. J., Kieboom, K., Marino, S., DePinho, R. A. & van Lohuizen, M. The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature 397, 164-168 (1999).
40. Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D. & Lowe, S. W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p161NK4a. Cell 88, 593-602 (1997).
41. Iavarone, A. & Massague, J. E2F and histone deacetylase mediate transforming growth factor beta repression of cdc25A during keratinocyte cell cycle arrest. Mol. Cell. Biol. 19, 916-922 (1999).